Title : Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Trastuzumab Followed by 5-Fluorouracil/Epirubicin/Cyclophosphamide for HER2-positive Operable Breast Cancer: A Multicenter Phase II Trial.

Pub. Date : 2019 Apr

PMID : 30952749

1 Functional Relationships(s)
Compound Name
Protein Name
1 CONCLUSION: Nab-paclitaxel plus trastuzumab followed by FEC in patients with HER2-positive operable breast cancer is considerably effective and well tolerated. nab erb-b2 receptor tyrosine kinase 2 Homo sapiens